Am J Transplant, Volume 21, Suppl 3 Archives - Page 59 of 139 - ATC Abstracts

2021 American Transplant Congress
Screening, Management and Acceptance of Patients with Aortoiliac Vascular Disease for Kidney Transplantation: An International Survey Among Transplant Surgeons
E. Rijkse¹, H. J. Kimenai¹, F. J. Dor², J. N. IJzermans³, R. C. Minnee¹
¹HPB/Transplant Surgery, Erasmus Medical Center, Rotterdam, Netherlands, ²Imperial College Transplant Centre, Hammersmith Hospital, London, United Kingdom, ³HPB/Transplant surgery, Erasmus Medical Center, Rotterdam, Netherlands
*Purpose: Aortoiliac vascular disease (AVD) is frequently observed during the work-up for kidney transplantation, but recommendations on its screening and management are lacking. We aimed…
2021 American Transplant Congress
Cost Savings Initiative with Idea Body Weight Dosing of Rabbit Anti-thymocyte Globulin (rATG) Induction in an Older Kidney Transplant Population: A Single Center Analysis
C. LaFratte¹, S. Witek¹, D. Sawinski², J. Trofe-Clark², C. Sammons², B. Hardek¹, R. Samudralwar¹, A. Forte¹, S. Lyle¹, J. Rashid¹, G. Malat²
¹Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia, PA, ²Penn Transplant Institute, Hospital of Univ of Pennsylvania, Philadelphia, PA
*Purpose: Optimal dosing schemes for rATG induction are not well defined for older kidney transplant recipients (KTRs), who are at greater risk for adverse events…
2021 American Transplant Congress
Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation
T. Le¹, J. Shoji², J. Phillips¹, D. Quan¹
¹Pharmaceutical Services, UCSF Medical Center, San Francisco, CA, ²Transplant Nephrology, UCSF Medical Center, San Francisco, CA
*Purpose: Belatacept, a selective T lymphocyte co-stimulation blocker, has been shown to be a safe and effective maintenance therapy for immunosuppression. We investigated the long-term…
2021 American Transplant Congress
The Impact of Diabetes on Young Transplant Recipients: An American Perspective
J. M. Loera, S. C. Barrett, T. S. Zhang, A. A. Awan, B. V. Murthy, R. T. Cotton, C. A. O'Mahany, N. T. Galvan, J. A. Goss, A. A. Rana
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: Our study aims to demonstrate the impact of diabetes, types I and II, on American young adults (18-40 years old) requiring kidney transplantation.*Methods: Using…
2021 American Transplant Congress
Alterations in Mineral Metabolism of Living Kidney Donors: Prospective Observational Study
H. Lee¹, E. Ko¹, H. Cho², C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, Korea, Republic of, ²Department of Urology, Seoul St. Mary’s Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study is to investigate whether reduction in glomerular filtration rate (GFR) after kidney donation causes mineral metabolism alterations, and also…
2021 American Transplant Congress
Is There a Role for Pre-Operative Angiographic Kidney Embolization Prior to Allograft Nephrectomy?
M. Jacobs¹, R. Stratta¹, D. Harriman², A. Farney¹, J. Rogers¹, G. Orlando¹, A. Reeves-Daniel¹, C. Jay¹
¹Wake Forest Baptist Health, Winston Salem, NC, ²University of British Columbia, Vancouver, BC, Canada
*Purpose: To determine if morbidity associated with allograft nephrectomy (AN) of a failed or diseased kidney transplant (KT) is improved by pre-operative angiographic kidney embolization…
2021 American Transplant Congress
The Differential Impact of Size Mismatch in Live versus Deceased Donor Kidney Transplant
A. J. Vinson¹, T. Skinner², B. Kiberd³, D. Clark¹, K. Tennankore¹
¹Division of Nephrology, Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada, ²Department of Urology, Nova Scotia Health Authority, Halifax, NS, Canada, ³Dalhousie University, Halifax, NS, Canada
*Purpose: The risk of significant weight mismatch between donors and recipients (D-R) undergoing living donor kidney transplant (LDKT) is not well established. Further, how this…
2021 American Transplant Congress
Development Following Pediatric Kidney Transplantation
L. Pape, J. Prüfe
Pediatrics II, University Hospital of Essen, Essen, Germany
*Purpose: Kidney transplantation for children suffering CKD5 has been established in Germany approximately 50 years ago. While in the early decades the focus was merely…
2021 American Transplant Congress
Utility of Donor-Derived Cell Free DNA for Detecting ABMR in Patients With AT1R Antibodies
S. Kant¹, D. Kumar², I. Moinuddin², T. Alhamad³, M. Haris³, J. Gray⁴, B. Dale⁴, M. Bettinotti¹, D. C. Brennan¹
¹Johns Hopkins University School of Medicine, Baltimore, MD, ²VCU, Richmond, VA, ³Wash Univ, St. Louis, MO, ⁴CareDx, Brisbane, CA
*Purpose: The presence of angiotensin II type 1 receptor (AT1R) antibodies is associated with non-HLA active antibody mediated rejection (ABMR). The frequent co-existence of negative…
2021 American Transplant Congress
Psmp is Discriminative for Chronic Active Antibody-Mediated Rejection and Predicts Graft Risk After Kidney Transplantation
Y. Fu, P. Zhan
Tianjin First Central Hospital, Tianjin, China
*Purpose: Chronic active antibody-mediated rejection (c-aABMR) is an intermediate process in the development of chronic antibody-mediated rejection (c-ABMR), a key problem in the long-term failure…